Yung Zip Chemical Ind. Co., Ltd. (TPEX:4102)
18.75
-0.05 (-0.27%)
Aug 19, 2026, 9:14 AM CST
Yung Zip Chemical Ind. Revenue
Yung Zip Chemical Ind. had revenue of 123.16M TWD in the quarter ending March 31, 2026, a decrease of -4.48%. This brings the company's revenue in the last twelve months to 468.44M, down -16.71% year-over-year. In the year 2025, Yung Zip Chemical Ind. had annual revenue of 474.22M, down -18.76%.
Revenue (ttm)
468.44M
Revenue Growth
-16.71%
P/S Ratio
1.61
Revenue / Employee
2.68M
Employees
184
Market Cap
796.62M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 474.22M | -109.47M | -18.76% |
| Dec 31, 2024 | 583.70M | 24.54M | 4.39% |
| Dec 31, 2023 | 559.15M | -8.18M | -1.44% |
| Dec 31, 2022 | 567.33M | 89.74M | 18.79% |
| Dec 31, 2021 | 477.60M | 14.38M | 3.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 20.75B |
| Healthconn | 1.13B |
| Kim Forest Enterprise | 599.63M |
| Meribank Biotech | 471.76M |
| Radiant Innovation | 389.45M |
| Taiwan Advance Bio-Pharmaceutical | 364.79M |
| General Biologicals | 215.74M |
| NatureWise Biotech & Medicals | 176.77M |